Leukodystrophy is a rare disease. It causes a break down of a part of the brain called the myelin, or “white matter". Myelin protects the part of the nerve that sends signals from the brain to the rest of the body. The break down of myelin makes it difficult for the brain to send signals to the body.
Types of leukodystrophies include:
Most leukodystrophies begin in infancy or childhood. However, there are several types that may not begin until adolescence or early adulthood.
Neuronal Axon With Myelin Sheath
Copyright © Nucleus Medical Media, Inc.
Leukodystrophy is caused by a genetic defect. This defect impairs the growth or development of the myelin. Each type of leukodystrophy is the result of a specific genetic defect. Most leukodystrophies are passed from parent to child though some may develop spontaneously.
Symptoms of leukodystrophy may include:
Some leukodystrophies may involve other organ systems which can cause:
Your doctor will ask about your symptoms and medical history. A physical exam will be done. Images of the brain may be taken. Your doctor may order a magnetic resonance imaging (MRI) to help diagnosis leukodystrophy. Other tests include:
Talk with your doctor about the best treatment plan for you. Treatment options include:
Depending on the type of leukodystrophy and the symptoms, treatment may include:
In a few of the leukodystrophies, bone marrow transplant may help. It may be able to slow or stop the progression of the disease.
Replacement of the abnormal or absent enzyme is being explored for a few of the leukodystrophies. Research is being done in this area.
Talk to your doctor to find out what treatments may be right for you.
There is no known way to prevent leukodystrophy. For parents who have had a child with leukodystrophy, genetic counseling may be helpful. This counseling will help to determine the chances of having another child with the disease.
National Institute of Neurological Disorders and Stroke
http://www.ninds.nih.gov/
United Leukodystrophy Foundation
http://www.ulf.org/
Bethany's Hope Foundation
http://www.bethanyshope.org/
Canadian Association for Tay-Sachs and Allied Diseases
http://www.catsad.ca/Index.htm/
DeKosky S, Kaufer D, Hamilton R, Wolk D, Lopez O. The dementias. In: Bradley WG, ed. Neurology in Clinical Practice. 5th ed. Philadelphia, PA: Butterworth Heinemann Elsevier; 2008.
DynaMed Editorial Team. Metachromatic leukodystrophy. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated January 20, 2011. Accessed September 20, 2012.
Genotype and protein expression after bone marrow transplantation for adrenoleukodystrophy. Arch Neurol . 2007;64:651-657.
Lamari F, et al. Disorders of phospholipids, sphingolibids, and fatty acids biosynthesis: toward a new category of inherited metabolic diseases. J Inherit metab Dis . 2012. July 20.
Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy [review]. Nat Clin Pract Neurol . 2007;3:140-151.
Ropper AH, Brown RH. Adams and Victor's Principles of Neurology . 8th ed. New York, NY: McGraw-Hill Medical Publishing Division; 2005: chap 37.
Leukodystrophy information page. National Institute of Neurological Disorders and Stroke website. Available at: http://www.ninds.n... . Accessed September 20, 2012.
Shimozawa N. Molecular and clinical aspects of peroxisomal diseases [review]. J Inherit Metab Dis . 2007;30:193-197.
United Leukodystrophy Foundation. What is leukodystrophy? United Leukodystrophy Foundation website. Available at: http://ulf.org/what-is-leukodystrophy . Accessed September 20, 2012.
Last reviewed September 2012 by Rimas Lukas, MD
Last Updated: 09/30/2012
Copyright © 2013 EBSCO Publishing All rights reserved.
Sponsored by iHerb.Com
Positively the best overall value for natural products!